tiprankstipranks
Advertisement
Advertisement

China BlueChemical Sets 2026 AGM to Approve Results, Dividends and New Share Mandate

Story Highlights
  • China BlueChemical will hold its 2026 AGM to approve 2025 results, dividends and auditor reappointments.
  • Shareholders will vote on board rule changes and a mandate to issue up to 20% new shares for flexibility.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
China BlueChemical Sets 2026 AGM to Approve Results, Dividends and New Share Mandate

Meet Samuel – Your Personal Investing Prophet

China BlueChemical ( (HK:3983) ) has issued an update.

China BlueChemical has convened its annual general meeting for 28 May 2026 in Haikou, where shareholders will review the board report, audited financial statements for 2025, and a proposed profit distribution including final dividends. They will also vote on reappointing Mazars ZSZH Certified Public Accountants LLP and Forvis Mazars CPA Limited as domestic and overseas auditors for 2026, with the audit committee authorised to set their remuneration.

Shareholders are further asked to approve amendments to the board’s procedural rules and to grant a general mandate allowing the board to issue up to 20% of existing domestic and H shares during a defined period, subject to PRC company law and regulatory approvals. The mandate, if passed, would give the company added flexibility in future equity financing and capital management, potentially affecting ownership dilution and the firm’s capacity to fund growth or strategic initiatives.

More about China BlueChemical

China BlueChemical Ltd. is a joint stock limited company incorporated in the People’s Republic of China and listed in Hong Kong. The company operates in the chemical and fertilizer sector, focusing on the production and sale of chemical and nitrogen-based products for domestic and overseas markets.

YTD Price Performance: 15.70%

Average Trading Volume: 14,757,984

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$12.91B

For an in-depth examination of 3983 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1